Innate Pharma SA (IPHA) — Earnings Call Analysis & IR Page

Innate Pharma SA is a Healthcare company operating in Biotechnology with a $207.8M market cap.

Most recent earnings call: Q1 FY26 on May 13, 2026.

20 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for IPHA.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 20 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for IPHA.

$ curl https://api.spokenalpha.com/v1/companies/IPHA

Get an API key API docs

FAQ

Frequently asked about IPHA

Where can I find Innate Pharma SA's (IPHA) earnings call transcripts?

Spoken Alpha indexes IPHA's earnings call transcripts at https://spokenalpha.com/companies/IPHA. Each call links to attributed speakers and parsed analyst Q&A.

When was Innate Pharma SA's most recent earnings call?

Innate Pharma SA (IPHA) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.

What sector is IPHA in?

Innate Pharma SA (IPHA) operates in the Healthcare sector (Biotechnology industry).

Overview